Pfm Health Sciences, LP’s Edwards Lifesciences Corp Position
Does Pfm Health Sciences, LP own Edwards Lifesciences Corp (EW)? Yes — 254.5K shares worth $20M (+1.86% of its 13F portfolio) as of Q1 2026, up from 246.8K shares the prior filed quarter.
Position Value
$20M
Q1 2026
Shares
254.5K
% of Portfolio
+1.86%
Quarters Held
30
currently held
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 254.5K | $20M | +1.86% |
| Q4 2025 | 246.8K | $21M | +2.10% |
| Q3 2025 | 381.3K | $30M | +2.28% |
| Q2 2025 | 392.5K | $31M | +2.61% |
| Q1 2025 | 380.0K | $28M | +2.00% |
| Q4 2024 | 594.2K | $44M | +2.73% |
| Q3 2024 | 390.9K | $26M | +1.46% |
| Q2 2024 | 740.3K | $68M | +3.38% |
| Q1 2024 | 740.3K | $71M | +3.33% |
| Q4 2023 | 740.3K | $56M | +3.39% |
| Q3 2023 | 702.6K | $49M | +2.29% |
| Q2 2023 | 702.6K | $66M | +2.57% |
| Q1 2023 | 648.6K | $54M | +2.37% |
| Q4 2022 | 530.0K | $40M | +1.42% |
| Q3 2022 | 480.3K | $40M | +1.44% |
| Q2 2022 | 338.2K | $32M | +1.23% |
| Q1 2022 | 338.2K | $40M | +1.49% |
| Q4 2021 | 373.5K | $48M | +1.65% |
| Q3 2021 | 513.0K | $58M | +1.71% |
| Q2 2021 | 513.0K | $53M | +1.67% |
| Q1 2021 | 513.0K | $43M | +1.31% |
| Q4 2020 | 487.8K | $45M | +1.57% |
| Q3 2020 | 487.8K | $39M | +1.80% |
| Q2 2020 | 393.4K | $27M | +1.41% |
| Q1 2020 | 118.4K | $22M | +1.83% |
| Q4 2019 | 103.3K | $24M | +1.15% |
| Q3 2019 | 251.8K | $55M | +1.63% |
| Q2 2019 | 456.4K | $84M | +1.60% |
| Q1 2019 | 360.3K | $69M | +1.52% |
| Q4 2018 | 540.8K | $83M | +2.20% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Pfm Health Sciences, LP’s full portfolio or all institutional holders of EW.